| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |